Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
222 studies found for:    "polycythemia vera"
Show Display Options
Rank Status Study
1 Completed Dasatinib in Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: Dasatinib
2 Terminated A Phase 1 Study of XL019 in Adults With Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: XL019
3 Completed
Has Results
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Condition: Polycythemia Vera
Interventions: Drug: Ruxolitinib;   Drug: Hydroxyurea (HU);   Drug: HU-placebo;   Drug: Ruxolitinib-placebo
4 Completed Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: pegylated interferon-alfa 2a
5 Completed Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera
Condition: Polycythemia Vera
Interventions: Drug: GIVINOSTAT (ITF2357) 50 mg o.d. + MTD Hydroxyurea;   Drug: GIVINOSTAT (ITF2357) 50 mg b.i.d. + MTD Hydroxyurea
6 Not yet recruiting Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features
Condition: Polycythemia Vera
Intervention: Other: questionnaires
7 Recruiting A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: Givinostat
8 Completed Treatment of Polycythemia Vera With Gleevec
Condition: Polycythemia Vera
Intervention: Drug: Gleevec
9 Recruiting Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Are Available.
Condition: Polycythemia Vera
Intervention: Drug: Ruxolitinib
10 Active, not recruiting Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Condition: Polycythemia Vera
Intervention:
11 Completed Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients
Condition: Polycythemia Vera
Intervention: Drug: Pegylated-Proline-Interferon alpha-2b in a Pre-filled Pen
12 Completed Effects of Imatinib Mesylate in Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: Imatinib Mesylate
13 Active, not recruiting AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
Condition: Polycythemia Vera
Interventions: Drug: Pegylated-Proline-interferon alpha-2b;   Drug: Best available therapy (BAT)
14 Active, not recruiting Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.
Condition: Polycythemia Vera
Interventions: Drug: Best Available Therapy;   Drug: ruxolitinib
15 Terminated Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: Erlotinib
16 Completed Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera
Condition: Polycythemia Vera
Interventions: Drug: Peg-P-IFN-alpha-2b (AOP2014);   Drug: Hydroxyurea
17 Terminated Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)
Condition: Polycythemia Vera
Interventions: Drug: Hydroxyurea;   Procedure: Phlebotomy
18 Active, not recruiting Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: PEG-P-INF alpha-2b (P1101)
19 Withdrawn Clopidogrel and Aspirin for the Treatment of Polycythemia Vera
Condition: Polycythemia Vera
Interventions: Drug: Clopidogrel (Plavix);   Drug: Placebo;   Drug: Aspirin
20 Active, not recruiting
Has Results
Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)
Condition: Polycythemia Vera
Interventions: Drug: ruxolitinib tablets;   Other: Best Available Therapy (BAT)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.